Sun Pharmaceutical (India) Today
| SUNPHARMA | 1,632 9.50 0.58% |
PerformanceWeakest
| Odds Of DistressLow
|
Sun Pharmaceutical is selling at 1632.10 as of the 5th of August 2025; that is 0.58 percent decrease since the beginning of the trading day. The stock's lowest day price was 1620.1. Sun Pharmaceutical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 7th of May 2025 and ending today, the 5th of August 2025. Click here to learn more.
Moving against Sun Stock
| 0.52 | LICI | Life Insurance Earnings Call This Week | PairCorr |
| 0.47 | BANKBARODA | Bank of Baroda | PairCorr |
| 0.39 | UEL | Ujaas Energy Limited Earnings Call This Week | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sun Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sun Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sun Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) |
Sun Pharmaceutical Industries (SUNPHARMA) is traded on National Stock Exchange of India in India and employs 43,000 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 3.94 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sun Pharmaceutical's market, we take the total number of its shares issued and multiply it by Sun Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sun Pharmaceutical operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 2.4 B outstanding shares.
Sun Pharmaceutical Industries has accumulated about 80.15 B in cash with 140.72 B of positive cash flow from operations.
Check Sun Pharmaceutical Probability Of Bankruptcy
Ownership AllocationSun Pharmaceutical shows a total of 2.4 Billion outstanding shares. Sun Pharmaceutical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sun Ownership Details
Sun Pharmaceutical Risk Profiles
Although Sun Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Sun Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.75 | |||
| Standard Deviation | 1.12 | |||
| Variance | 1.25 | |||
| Risk Adjusted Performance | (0.08) |
Sun Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sun Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Sun Pharmaceutical Corporate Management
Elected by the shareholders, the Sun Pharmaceutical's board of directors comprises two types of representatives: Sun Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sun. The board's role is to monitor Sun Pharmaceutical's management team and ensure that shareholders' interests are well served. Sun Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sun Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Abhishek Sharma | Head VP | Profile | |
| Marek Honczarenko | Head Development | Profile | |
| Sailesh Desai | Whole Director | Profile | |
| Sapna Purohit | VP HR | Profile | |
| Uday Baldota | Chief Ltd | Profile | |
| Jila Breeze | Executive Quality | Profile | |
| Damodharan | Chief Business | Profile |
Additional Tools for Sun Stock Analysis
When running Sun Pharmaceutical's price analysis, check to measure Sun Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sun Pharmaceutical is operating at the current time. Most of Sun Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sun Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sun Pharmaceutical's price. Additionally, you may evaluate how the addition of Sun Pharmaceutical to your portfolios can decrease your overall portfolio volatility.